Histotripsy and Immunotherapy

  • Histotripsy and Immunotherapy

    Posted by vegandan on February 7, 2025 at 1:46 pm EST

    Does anyone have any personal or professional experience with histotripsy for liver cancer? Here is a podcast that was an introduction to the topic. Seems like an innovative approach to helping people deal with this cancer and perhaps other cancers in the future. The therapy is based on focused ultrasound. https://www.youtube.com/watch?v=CY35RgdoROc

    Unknown Member replied 1 week, 1 day ago 3 Members · 2 Replies
  • 2 Replies
  • Kathy Kopp

    Member
    February 7, 2025 at 8:59 pm EST

    I don’t have specific experience with these options. There may be something on this website as they have an active research group:

    The Cholangiocarcinoma Foundation

  • Unknown Member

    Member
    March 11, 2025 at 12:11 am EDT

    Histotripsy and Immunotherapy in Cancer Treatment 1. What is Histotripsy?

    Histotripsy is a non-invasive, ultrasound-based therapy that uses high-intensity focused ultrasound (HIFU) to mechanically destroy tumors without surgery, radiation, or heat. Instead of thermal ablation, it breaks down cancer cells using acoustic cavitation—creating microbubbles that disrupt the tumor.

    2. How Does Histotripsy Relate to Immunotherapy?

    Recent research suggests histotripsy can enhance the body’s immune response, making it a potential partner for immunotherapy:

    • Releases Tumor Antigens – The destruction of tumor cells by histotripsy releases cancer antigens, which can help the immune system recognize and attack cancer cells.
    • Reduces Immunosuppressive Factors – Tumors often suppress immune responses, but histotripsy may help disrupt these protective environments.
    • Synergy with Immune Checkpoint Inhibitors – By exposing tumor fragments to the immune system, histotripsy may boost the effects of drugs like PD-1 inhibitors (Keytruda, Opdivo), which help immune cells attack cancer.

    3. Recent Studies & Advancements

    • University of Michigan Research (2022-2024):
      • Found that histotripsy destroys primary tumors and prevents metastasis in liver cancer models.
      • Suggested that histotripsy triggers an anti-tumor immune response, making it a potential combination therapy with immunotherapy.
    • Ongoing Clinical Trials:
      • Histotripsy is being tested for liver, kidney, and pancreatic cancers in human trials.
      • Some trials are investigating its combination with checkpoint inhibitors and CAR-T cell therapy.

    4. Potential Benefits Over Traditional Treatments

    Non-invasive, no incisions
    Lower risk of complications compared to surgery and radiation
    Targets tumors precisely while sparing healthy tissue
    May reduce metastasis and recurrence when combined with immunotherapy

    Future of Histotripsy & Immunotherapy

    • Researchers are exploring whether histotripsy can “prime” tumors for immunotherapy, making resistant cancers more treatable.
    • If successful, this could lead to a new standard of care for solid tumors, especially in cases where surgery is not an option.

Log in to reply.